3 Big Pharmas That Have Had Big Months Headed Into Year's End

|
Includes: BMY, LLY, MYL
by: Kinetic Investments

On Friday, I wrote an article, 3 Biotechs That Were Crushed This Week And Why. I've decided to follow it up with an article about little Biotech's more stable and profitable older sibling: Big Pharma.

In a space that will likely continue to consolidate next year as it endures increasing regulatory scrutiny while fighting global governments' efforts to cut spending costs on healthcare, I have identified 3 big pharmas that have performed quite nicely over the last 30 days and have both market and sector outperforming potential for next year.

1. Bristol-Myers Squibb Company (NYSE:BMY)

Bristol-Myers Squibb is a company that is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis.

Over the last 30 days, the stock has risen more than 14.5% from its low of $30.10, which was set on November 25th, to its new 52 week high of $34.50, which was forged on Friday. The stock seems to have a full head of steam headed into the new year.

BMY 30 Day Chart (click charts to enlarge)
BMY ChartClick to enlarge

What's been happening at Bristol-Myers Squibb over the last 30 days?

2. Eli Lilly and Company (NYSE:LLY)

Eli Lilly is a company that discovers, develops, manufactures and sells products in one business segment, pharmaceutical products. It also has an animal health business segment.

The stock is up more than 16.75% from its 30 day low of $35.46, which hit the tape on November 25th, rising to its new 52 week high of $41.43, which was set on Friday. Eli Lilly is another Big Pharma that looks to close the year out on a strong note.

LLY 30 Day Chart
LLY ChartClick to enlarge

What's been happening at Eli Lilly over the last 30 days?

3. Mylan Inc. (NASDAQ:MYL)

Mylan is a generic and specialty pharmaceutical company, which provides products to customers in more than 150 countries and territories.

During the last 30 days, MYL has surged more than 22% from its low of $17.22, which was recorded on November 22nd, to its one month high of $21.07, which was set on Friday. The stock currently trades about 18% below its 52 week high of $25.46, set in late April.

MYL 30 Day Chart
MYL ChartClick to enlarge

What's been happening at Mylan over the last 30 days?

I believe all three of the above names are worth considering for a well balanced and diversified 2012 portfolio and I plan to monitor them closely in hopes of exploiting any good buying opportunities that present themselves

Disclosure: I am long LLY.